Huntington Bancshares Incorporated · HBAN · FY2026 Q1 · Calendar Q2 2026
Huntington beats Q1 estimates on fee strength; raises fee-growth outlook, trims NIM view
Huntington enters 2026 with double-digit growth ambition anchored on M&A integration (Cadence, Veritex, Janney, TM Capital) and fee expansion across payments, wealth and capital markets. The Q1 beat rested on fee strength and disciplined cost control, with full synergies targeted by Q4. Sustained performance hinges on delivering those synergies, holding NIM near the high 3.20% range amid deposit pricing pressure, and managing commercial real-estate exposure.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about HBAN FY2026 Q1
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Huntington reported Q1 2026 adjusted EPS of $0.25, a 9.6% beat versus the $0.2282 consensus, on revenue of $2.592B that edged expectations by roughly 1%. Management trimmed the NIM outlook to the high 3.20% range but raised fee-income growth guidance to 31-33%, and expanded the buyback to a $3 billion evergreen authorization while upgrading the ROTCE target to 18-19%.
Guidance delta
Guidance broadly maintained but with a mixed change: the NIM outlook was revised down to the high 3.20% range while fee-income growth guidance was raised to 31-33%, funded partly by a roughly 80 bps CET1 benefit modeled under Basel III Endgame.
Key takeaways
- Q1 delivered 9% adjusted EPS growth and 36% adjusted PPNR growth, powered by strong fee income and loan/deposit momentum.
- Integration of Cadence, Veritex, Janney and TM Capital is on schedule, with cost and revenue synergies expected to be fully realized by Q4.
- NIM outlook was revised down to the high 3.20% range, while fee-income growth guidance was lifted to 31-33%.
- Balance sheet remains strong: liquidity 173% of uninsured deposits, LCR 118%, CET1 in the 9-10% range.
- The board expanded the share-repurchase program to a $3 billion evergreen authorization, with $550 million planned for 2026.
Management priorities
- Complete Cadence systems conversion by June and achieve full run-rate synergies by Q4.
- Continue branch expansion in the Carolinas and digital rollout in Texas and the South.
- Invest in an enterprise-wide AI program to enhance productivity and customer-facing capabilities.
- Reinvest synergy proceeds into talent, digital platforms, payments and wealth-management capabilities.
- Maintain an aggressive share-repurchase program under the new $3 billion authorization.
Follow HBAN with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 25, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Buy | Buy | Maintain | Sep 23, 2026 |
| DA Davidson | Buy | Buy | Maintain | Sep 21, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Sep 18, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Sep 16, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 18, 2026 |
| B of A Securities | Neutral | Buy | Downgrade | Jul 27, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Jul 24, 2026 |
| Morgan Stanley | Equal Weight | Overweight | Downgrade | Jul 24, 2026 |
| Baird | Outperform | Outperform | Maintain | Jul 24, 2026 |
| UBS | Buy | Buy | Maintain | Jul 7, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 6, 2026 |
| Jefferies | Hold | Buy | Downgrade | Jul 6, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jan 23, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jan 5, 2026 |
| Piper Sandler | Underweight | Underweight | Maintain | Dec 10, 2025 |
| TD Cowen | Buy | Buy | Maintain | Oct 20, 2025 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Oct 20, 2025 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jul 3, 2025 |
| Citigroup | Buy | Buy | Maintain | Jul 2, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Nov 26, 2024 |
| Argus Research | Buy | Buy | Maintain | Jul 22, 2024 |
| Wedbush | Neutral | Neutral | Maintain | Apr 21, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | Sep 12, 2022 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 24, 2020 |
| Nomura | Neutral | Neutral | Maintain | Apr 7, 2020 |
| CFRA | Hold | Hold | Maintain | Apr 6, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Oct 25, 2019 |
| Macquarie | Underperform | Neutral | Downgrade | Jul 12, 2019 |
| Argus | Hold | Hold | Maintain | May 31, 2019 |
| Sandler O'Neill | Hold | Buy | Downgrade | Nov 29, 2018 |
| Hilliard Lyons | Buy | Neutral | Upgrade | Feb 9, 2018 |
| Bernstein | Outperform | Market Perform | Upgrade | Sep 14, 2017 |
| JMP Securities | Perform | Market Perform | Maintain | Aug 31, 2017 |
| PiperJaffray | Overweight | Neutral | Upgrade | Aug 11, 2017 |
| FBR Capital | Market Perform | Outperform | Downgrade | Oct 11, 2016 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Apr 6, 2016 |
| Sterne Agee | Buy | Neutral | Upgrade | Apr 6, 2016 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 22, 2016 |
| Guggenheim | Buy | Neutral | Upgrade | Aug 28, 2015 |
| CLSA | Underperform | Underperform | Maintain | Jul 8, 2015 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Jun 29, 2015 |
| Canaccord Genuity | Hold | Buy | Downgrade | May 11, 2015 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | Apr 24, 2015 |
| Miller Tabak | Buy | Hold | Upgrade | Mar 9, 2015 |
| Portales Partners | Sector Perform | Underperform | Upgrade | Jul 21, 2014 |
| ISI Group | Neutral | Neutral | Maintain | Oct 7, 2013 |
| Compass Point | Neutral | Buy | Downgrade | Apr 18, 2013 |
| Evercore Partners | Overweight | Equal Weight | Upgrade | Dec 19, 2012 |
| Bank oferica | Buy | Buy | Maintain | May 9, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $15.64. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Analyst unavailable | $19 | $15.69 | +21.5% | Sep 23, 2026 |
| D.A. Davidson | Peter Winter | $20 | $15.94 | +27.9% | Sep 21, 2026 |
| Wells Fargo | Analyst unavailable | $21 | $15.93 | +34.3% | Sep 16, 2026 |
| Wells Fargo | Mike Mayo | $23 | $17.91 | +47.1% | Aug 17, 2026 |
| Truist Financial | Analyst unavailable | $20 | $17.24 | +27.9% | Jul 28, 2026 |
| Robert W. Baird | David George | $21 | $17.4 | +34.3% | Jul 24, 2026 |
| Stephens | Analyst unavailable | $19 | $17.4 | +21.5% | Jul 24, 2026 |
| Jefferies | Analyst unavailable | $18 | $17.4 | +15.1% | Jul 23, 2026 |
| UBS | Analyst unavailable | $22 | $18.03 | +40.7% | Jul 7, 2026 |
| Evercore ISI | John Pancari | $21 | $17.76 | +34.3% | Jul 6, 2026 |
| Jefferies | Analyst unavailable | $19 | $17.86 | +21.5% | Jul 6, 2026 |
| Morgan Stanley | Analyst unavailable | $21 | $17.81 | +34.3% | Jun 29, 2026 |
| Evercore ISI | Analyst unavailable | $20 | $17.21 | +27.9% | Jun 12, 2026 |
| Piper Sandler | Analyst unavailable | $18 | $16.62 | +15.1% | Apr 23, 2026 |
| Robert W. Baird | Analyst unavailable | $20 | $16.12 | +27.9% | Mar 9, 2026 |
| UBS | Analyst unavailable | $21 | $19.08 | +34.3% | Feb 4, 2026 |
| National Bank | Manan Gosalia | $21 | $18.39 | +34.3% | Feb 4, 2026 |
| RBC Capital | Analyst unavailable | $21 | $17.8 | +34.3% | Jan 12, 2026 |
| Wolfe Research | Analyst unavailable | $21 | $18.1 | +34.3% | Jan 7, 2026 |
| Goldman Sachs | Ryan Nash | $21 | $17.99 | +34.3% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $20 | $17.48 | +27.9% | Jan 5, 2026 |
| RBC Capital | Analyst unavailable | $20 | $17.62 | +27.9% | Dec 19, 2025 |
| Piper Sandler | Analyst unavailable | $16 | $17 | +2.3% | Dec 10, 2025 |
| Evercore ISI | John Pancari | $18 | $15.97 | +15.1% | Oct 21, 2025 |
| Morgan Stanley | Analyst unavailable | $23 | $17.42 | +47.1% | Sep 29, 2025 |
| Argus Research | Kevin Heal | $17 | $14.46 | +8.7% | Apr 25, 2025 |
| Truist Financial | Brian Foran | $21 | $16.55 | +34.3% | Jan 21, 2025 |
| Citigroup | Keith Horowitz | $18 | $15.36 | +15.1% | Oct 21, 2024 |
| Piper Sandler | Scott Siefers | $15 | $15.43 | -4.1% | Oct 18, 2024 |
| Morgan Stanley | Manan Gosalia | $18 | $13.75 | +15.1% | Aug 5, 2024 |
| Robert W. Baird | David George | $15 | $15.06 | -4.1% | Jul 26, 2024 |
| Argus Research | Kevin Heal | $16 | $15.01 | +2.3% | Jul 22, 2024 |
| RBC Capital | Jon Arfstrom | $17 | $14.86 | +8.7% | Jul 22, 2024 |
| Morgan Stanley | Manan Gosalia | $16 | $14.8 | +2.3% | Jul 22, 2024 |
| D.A. Davidson | Peter Winter | $17.5 | $15.01 | +11.9% | Jul 22, 2024 |
| Stephens | Terry McEvoy | $16 | $15.01 | +2.3% | Jul 22, 2024 |
| Piper Sandler | Scott Siefers | $11.5 | $12.34 | -26.5% | Jun 14, 2024 |
| Piper Sandler | Scott Siefers | $13.5 | $12.77 | -13.7% | Jun 10, 2024 |
| Jefferies | Ken Usdin | $16 | $13.6 | +2.3% | Apr 8, 2024 |
| Stephens | Terry McEvoy | $15 | $13.95 | -4.1% | Apr 1, 2024 |
| UBS | Erika Naharian | $15 | $12.72 | -4.1% | Feb 14, 2024 |
| D.A. Davidson | Analyst unavailable | $15 | $14 | -4.1% | Dec 21, 2022 |
| J.P. Morgan | Analyst unavailable | $14.5 | $14.54 | -7.3% | Dec 13, 2022 |
| Morgan Stanley | Analyst unavailable | $19 | $15.46 | +21.5% | Dec 5, 2022 |
| Raymond James | Analyst unavailable | $18 | $14.1 | +15.1% | Apr 22, 2022 |
| RBC Capital | Jon Arfstrom | $19 | $15.03 | +21.5% | Jan 21, 2022 |
| Barclays | Jason Goldberg | $17 | $15.64 | +8.7% | Jan 3, 2022 |
| Stephens | Terry McEvoy | $17.5 | $15.55 | +11.9% | Nov 9, 2021 |
| Goldman Sachs | Ryan Nash | $18 | $14.27 | +15.1% | Aug 18, 2021 |
| KBW | David Konrad | $15 | $13.56 | -4.1% | Jul 6, 2021 |
Track every rating change on HBAN the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationHuntington Bancshares Incorporated, established in Columbus, Ohio, in 1866, operates as the bank holding company for The Huntington National Bank, providing a comprehensive suite of commercial, consumer, and mortgage banking services across the United States. Its operations are organized into four key segments. The Consumer and Business Banking segment offers essential financial products to individuals and small businesses, including checking, savings, money market, and certificate of deposit accounts, along with credit cards, various loans, and investment opportunities. This segment also facilitates mortgages, insurance, interest rate risk protection, foreign exchange, and provides convenient access through ATMs, online, mobile, and telephone banking.…
Historical context
All HBAN earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| PUK Prudential plc | FY2026 Q2 · Calendar Q3 2026 | -40.9% | -0.5% | Prudential sustains growth and capital returns focus in H1 2026 |
| CM Canadian Imperial Bank of Commerce | FY2026 Q3 · Calendar Q3 2026 | +8.9% | -2.8% | CIBC Q3: Broad growth, resilient credit and expanded AI rollout |
| TD The Toronto-Dominion Bank | FY2026 Q3 · Calendar Q3 2026 | +13.8% | +1.4% | TD emphasizes growth investments alongside disciplined capital management |
| RY Royal Bank of Canada | FY2026 Q3 · Calendar Q3 2026 | +6.2% | -1.3% | RBC reports record Q3 earnings while investing for growth |
| AFRM Affirm Holdings, Inc. | FY2026 Q4 · Calendar Q3 2026 | +1230.3% | +0.3% | Affirm's most profitable quarter shifts focus to product execution |
Latest beats and misses
Who reports nextBeat on EPS
- SNXFY2026 Q3 · September 24, 2026+20.9% EPS-9.9% move
- DRIFY2027 Q1 · September 24, 20260.0% EPS-3.0% move
- CTASFY2027 Q1 · September 23, 2026+3.0% EPS-3.4% move
- PAYXFY2027 Q1 · September 23, 2026+1.5% EPS-8.8% move
- GISFY2027 Q1 · September 23, 2026+4.6% EPS+1.0% move
- AZOFY2026 Q4 · September 22, 2026+3.6% EPS+3.3% move
Get the HBAN recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-09-25T19:01:46.758678+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-25T19:01:46.756231+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-25. For educational purposes only; not investment advice.